See more : AbbVie Inc. (0QCV.L) Income Statement Analysis – Financial Results
Complete financial analysis of U.S. Physical Therapy, Inc. (USPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U.S. Physical Therapy, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Cocoon Holdings Limited (0428.HK) Income Statement Analysis – Financial Results
- Lake Area Corn Processors, LLC (LKCRU) Income Statement Analysis – Financial Results
- Meyer Apparel Limited (MAL.BO) Income Statement Analysis – Financial Results
- Location Sciences Group PLC (LSAI.L) Income Statement Analysis – Financial Results
- Prevas AB (PREV-B.ST) Income Statement Analysis – Financial Results
U.S. Physical Therapy, Inc. (USPH)
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M | 252.09M | 237.01M | 211.23M | 201.41M | 187.69M | 151.69M | 135.19M | 132.12M | 118.31M | 105.57M | 94.74M | 80.95M | 63.22M | 49.94M | 44.00M | 38.80M | 32.20M | 24.90M | 17.20M | 8.40M | 2.40M | 600.00K |
| Cost of Revenue | 492.82M | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M | 323.43M | 274.53M | 252.94M | 228.91M | 199.36M | 189.50M | 172.51M | 151.82M | 146.24M | 140.08M | 114.33M | 99.35M | 96.21M | 85.28M | 74.60M | 64.53M | 54.88M | 42.90M | 34.09M | 30.80M | 27.30M | 22.10M | 17.40M | 13.20M | 6.20M | 1.70M | 500.00K |
| Gross Profit | 111.99M | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M | 90.62M | 82.01M | 78.36M | 76.17M | 64.70M | 62.59M | 64.49M | 59.42M | 55.17M | 47.60M | 37.36M | 35.84M | 35.91M | 33.03M | 30.96M | 30.21M | 26.07M | 20.32M | 15.84M | 13.20M | 11.50M | 10.10M | 7.50M | 4.00M | 2.20M | 700.00K | 100.00K |
| Gross Profit Ratio | 18.52% | 20.25% | 23.67% | 22.33% | 23.34% | 22.40% | 21.89% | 23.00% | 23.65% | 24.97% | 24.50% | 24.83% | 27.21% | 28.13% | 27.39% | 25.36% | 24.63% | 26.51% | 27.18% | 27.92% | 29.33% | 31.89% | 32.20% | 32.14% | 31.73% | 30.00% | 29.64% | 31.37% | 30.12% | 23.26% | 26.19% | 29.17% | 16.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -9.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.43M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 4.20M | 4.50M | 3.50M | 1.70M | 400.00K |
| Other Expenses | 0.00 | 859.00K | -4.60M | -13.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79M | 3.24M | 3.35M | 0.00 | 0.00 | 0.00 | 604.00K | 238.00K | 0.00 | 0.00 | 0.00 | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| Operating Expenses | 42.43M | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 28.56M | 26.23M | 26.74M | 23.73M | 17.33M | 17.25M | 17.03M | 17.04M | 13.97M | 11.33M | 9.12M | 9.94M | 8.58M | 7.70M | 6.70M | 6.50M | 5.90M | 5.80M | 4.10M | 1.90M | 400.00K |
| Cost & Expenses | 535.25M | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M | 359.32M | 307.01M | 284.01M | 259.31M | 225.29M | 214.29M | 201.08M | 178.04M | 172.98M | 163.81M | 131.65M | 116.60M | 113.24M | 102.32M | 88.57M | 75.87M | 64.00M | 52.84M | 42.67M | 38.50M | 34.00M | 28.60M | 23.30M | 19.00M | 10.30M | 3.60M | 900.00K |
| Interest Income | 3.77M | 859.00K | 199.00K | 142.00K | 46.00K | 93.00K | 88.00K | 93.00K | 81.00K | 18.00K | 7.00K | 6.00K | 5.45M | 586.00K | 8.00K | 260.00K | 273.00K | 332.00K | 361.00K | 146.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.30M | 5.78M | 942.00K | 1.63M | 2.08M | 2.04M | 21.06M | 11.48M | 1.03M | 1.09M | 538.00K | 557.00K | 496.00K | 236.00K | 352.00K | 542.00K | 301.00K | 0.00 | 361.00K | 0.00 | 189.00K | 214.00K | 266.00K | 780.00K | 727.00K | 700.00K | 0.00 | 700.00K | 700.00K | 600.00K | 200.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 15.70M | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.90M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| EBITDA | 74.37M | 76.09M | 85.73M | 77.68M | 83.08M | 72.01M | 64.53M | 58.41M | 55.33M | 52.53M | 44.34M | 43.10M | 46.83M | 39.44M | 34.16M | 30.10M | 25.02M | 23.09M | 24.84M | 20.83M | 20.59M | 21.83M | 19.51M | 12.72M | 9.36M | 7.60M | 6.70M | 5.30M | 3.30M | -500.00K | -1.30M | -1.00M | -300.00K |
| EBITDA Ratio | 12.30% | 14.95% | 17.85% | 18.11% | 17.24% | 15.46% | 15.58% | 16.38% | 16.70% | 17.22% | 16.79% | 17.10% | 19.76% | 18.67% | 17.05% | 15.90% | 16.50% | 17.08% | 18.01% | 17.37% | 19.50% | 23.04% | 24.11% | 20.11% | 18.74% | 17.73% | 17.27% | 16.46% | 12.05% | -2.91% | -15.48% | -41.67% | -50.00% |
| Operating Income | 69.56M | 56.80M | 76.77M | 52.41M | 67.43M | 60.31M | 54.73M | 49.53M | 47.29M | 45.77M | 38.77M | 37.80M | 35.93M | 33.19M | 28.43M | 23.88M | 20.04M | 18.60M | 18.88M | 15.99M | 17.00M | 18.87M | 16.95M | 10.38M | 7.27M | 5.50M | 4.80M | 3.60M | 1.60M | -1.80M | -1.90M | -1.20M | -300.00K |
| Operating Income Ratio | 11.50% | 10.27% | 15.51% | 12.39% | 13.99% | 13.29% | 13.22% | 13.89% | 14.28% | 15.00% | 14.68% | 15.00% | 15.16% | 15.71% | 14.11% | 12.72% | 13.21% | 13.76% | 14.29% | 13.52% | 16.10% | 19.92% | 20.94% | 16.42% | 14.55% | 12.50% | 12.37% | 11.18% | 6.43% | -10.47% | -22.62% | -50.00% | -50.00% |
| Total Other Income/Expenses | -20.18M | -1.23M | 2.55M | 13.10M | 3.48M | -103.00K | -20.97M | -11.39M | -7.16M | -1.07M | -531.00K | 52.00K | 446.00K | 350.00K | -344.00K | -282.00K | -5.76M | -5.35M | -5.61M | -366.00K | -5.16M | -5.06M | -5.45M | -4.25M | -3.30M | -2.80M | -2.30M | -1.90M | 300.00K | 0.00 | 0.00 | 0.00 | 300.00K |
| Income Before Tax | 49.38M | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M | 33.76M | 38.15M | 46.34M | 44.70M | 38.24M | 37.25M | 40.88M | 33.54M | 28.08M | 16.51M | 14.28M | 13.25M | 14.30M | 10.78M | 11.78M | 13.72M | 11.50M | 6.14M | 3.96M | 2.70M | 2.50M | 1.70M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 8.16% | 10.05% | 14.79% | 15.49% | 14.71% | 13.26% | 8.15% | 10.70% | 13.99% | 14.65% | 14.48% | 14.78% | 17.25% | 15.88% | 13.94% | 8.80% | 9.41% | 9.80% | 10.82% | 9.11% | 11.16% | 14.49% | 14.21% | 9.71% | 7.93% | 6.14% | 6.44% | 5.28% | 7.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.16M | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M | 6.03M | 11.88M | 14.65M | 14.27M | 12.24M | 11.03M | 11.10M | 8.84M | 8.11M | 6.51M | 5.47M | 5.06M | 5.51M | 4.10M | 4.45M | 5.24M | 4.43M | 2.40M | 1.57M | 1.10M | 100.00K | 100.00K | 900.00K | 1.00M | 300.00K | 0.00 | 200.00K |
| Net Income | 14.67M | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M | 17.93M | 20.97M | 15.65M | 11.77M | 10.00M | 8.89M | 6.30M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.74M | 2.39M | 1.60M | 2.40M | 1.60M | 700.00K | -2.80M | -2.20M | -1.20M | -200.00K |
| Net Income Ratio | 2.43% | 7.85% | 11.70% | 12.41% | 11.88% | 2.23% | 5.38% | 5.76% | 6.72% | 6.48% | 4.82% | 7.11% | 8.85% | 7.41% | 5.84% | 5.33% | 5.86% | 4.66% | 6.65% | 5.64% | 6.94% | 8.96% | 8.74% | 5.91% | 4.79% | 3.64% | 6.19% | 4.97% | 2.81% | -16.28% | -26.19% | -50.00% | -33.33% |
| EPS | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.52 | 1.78 | 1.34 | 1.01 | 0.84 | 0.75 | 0.54 | 0.74 | 0.56 | 0.66 | 0.77 | 0.70 | 0.13 | 0.12 | 0.05 | 0.08 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| EPS Diluted | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 | 0.83 | 0.75 | 0.54 | 0.73 | 0.54 | 0.61 | 0.67 | 0.55 | 0.11 | 0.11 | 0.05 | 0.07 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| Weighted Avg Shares Out | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.06M | 11.80M | 11.81M | 11.64M | 11.70M | 11.91M | 11.64M | 11.69M | 11.92M | 11.93M | 11.11M | 11.02M | 10.10M | 9.56M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
| Weighted Avg Shares Out (Dil) | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.08M | 11.90M | 11.98M | 11.87M | 11.81M | 12.06M | 11.72M | 11.69M | 12.04M | 12.37M | 12.02M | 12.67M | 12.86M | 10.70M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q2 2022 Results - Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q2 2022 Earnings Conference Call August 4, 2022 10:30 AM ET Company Participants Chris Reading - President and Chief Executive Officer Carey Hendrickson - Chief Financial Officer Eric Williams - Co-Chief Operating Officer Graham...
U.S. Physical Therapy Reports Second Quarter 2022 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, today reported results for the second quarter and six months ended June 30,...
U.S. Physical Therapy Reports Second Quarter 2022 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, today reported results for the second quarter and six months ended June 30,...
U.S. Physical Therapy, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for Thursday, August 4, 2022
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will issue its financial results for the second quarter and six months ended June 30,...
U.S. Physical Therapy Announces Closing of New Credit Facility
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced the closing of a $325 million, five-year credit facility that includes a...
U.S. Physical Therapy to Present at the 2022 East Coast IDEAS Virtual Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the "Company"), today announced that Carey Hendrickson, Chief Financial Officer, will participate in the 2022 East Coast IDEAS...
3 Stocks to Watch From a Buoyant Outpatient Home Health Industry
Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JON BATES AS ITS NEW CHIEF FINANCIAL OFFICER
HOUSTON , June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population...
U.S. Physical Therapy to Present at the Jefferies Healthcare Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the "Company"), today announced that Chris Reading, Chief Executive Officer, and Carey Hendrickson, Chief Financial Officer, will participate...
U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q1 2022 Results - Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q1 2022 Earnings Conference Call May 5, 2022 10:30 AM ET Company Participants Chris Reading - President and Chief Executive Officer Carey Hendrickson - Chief Financial Officer Graham Reeve - Co-Chief Operating Officer Eric...
Source: https://incomestatements.info
Category: Stock Reports